Literature DB >> 7453819

Is erythropoietin the only factor which regulates late erythroid differentiation?

B Fagg.   

Abstract

Haematopoiesis is a useful model system for studying differentiation and the regulation of precursor cell populations intermediate between the multipotential stem cell and terminally differentiated end cells. For many years, erythropoietin (Epo) was recognized as the hormone which controls red cell production in vivo. Although other substances are now known to be required during the initial stages of erythropoiesis, late erythroid differentiation is regarded as strictly Epo-dependent. This concept is supported by the recent demonstration that the addition of Epo alone to serum-free bone marrow cell cultures is sufficient to stimulate the CFU-E (colony-forming unit-erythroid-a late erythroid precursor cell approximating to a proerythroblast) to complete differentiation into mature erythrocytes. However, the data reported here indicate that mature erythroid colonies (indistinguishable from those formed by CFU-E + Epo) are formed when adult bone marrow cells are grown for 2 d in methyl cellulose cultures containing spleen cell-conditioned medium (SCM) but no added EPO. SCM is a rich source of growth factors and initial observations suggested that its 'Epo-like' activity could be attributed to: (1) Epo, or (2) a factor which enhances the activity of small amounts of Epo in the culture medium, or (3) a factor(s) distinct from Epo which is also capable of stimulating late erythroid differentiation. The experiments reported here, which include a partial characterization of the 'Epo-like' activity, support the latter interpretation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7453819     DOI: 10.1038/289184a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  8 in total

1.  Colony formation by primitive hemopoietic progenitor cells in serum-free medium.

Authors:  J F Eliason; N Odartchenko
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.

Authors:  M A Smith; S M Knight; P J Maddison; J G Smith
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  Erythropoietin changes the globin program of an interleukin 3-dependent multipotential cell line.

Authors:  T Enver; B Nakamoto; J Karlinsey; B Josephson; J Greenberger; T Papayannopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Production of erythropoietin-like activity by a murine erythroleukemia cell line.

Authors:  P Tambourin; N Casadevall; J Choppin; C Lacombe; J M Heard; S Fichelson; F Wendling; B Varet
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 5.  Erythropoietin: a review.

Authors:  D M Ridley; F Dawkins; E Perlin
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

6.  Mouse yolk sac and intraembryonic tissues produce factors able to elicit differentiation of erythroid burst-forming units and colony-forming units, respectively.

Authors:  M C Labastie; J P Thiery; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin.

Authors:  J W Goodman; E A Hall; K L Miller; S G Shinpock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 8.  Compensatory neoplasia: chronic erythrocytosis and neuroblastic tumors.

Authors:  S M de la Monte; G M Hutchins; G W Moore
Journal:  Theor Med       Date:  1984-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.